| 11/17/2026 3:41 PM | Dolby Laboratories (1308547) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 11/13/2026 4:19 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2026 3:08 PM | Dolby Laboratories (1308547) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 10/27/2026 8:51 AM | Dolby Laboratories (1308547) Subject FIRST TRUST PORTFOLIOS LP (1184765) Filed by | Form SCHEDULE 13G | |
| 10/22/2026 12:13 PM | Bank of New York Mellon Corp (1390777) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13G/A | |
| 10/05/2026 7:42 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 5:42 PM | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 (1598813) Reporting Dolby Dagmar (1537372) Reporting Dolby Laboratories (1308547) Issuer MARITAL TRUST UNDER DOLBY FAMILY TRUST DATED MAY 7, 1999 (1598817) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 4:08 PM | Dolby Laboratories (1308547) Issuer Whitten Marc (1848572) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 4:03 PM | Dolby Laboratories (1308547) Issuer SHERMAN MARK ANDREW (1256708) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 4:05 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:30 PM | Dolby Laboratories (1308547) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for DLB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/03/2026 6:33 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/01/2026 3:18 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/28/2026 5:01 PM | Dolby Laboratories (1308547) Issuer Whitten Marc (1848572) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/28/2026 5:02 PM | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 (1598813) Reporting Dolby Dagmar (1537372) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2026 7:15 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/27/2026 8:00 AM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/25/2026 3:06 PM | Dolby Laboratories (1308547) Subject Nicholson Ryan (1767009) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 4:14 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 3:30 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/10/2026 3:15 PM | Dolby Laboratories (1308547) Subject Nicholson Ryan (1767009) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 4:28 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 4:11 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 3:37 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/30/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/06/2026 4:39 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 11:12 AM | BlackRock, Inc. (2012383) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13G/A | |
| 06/03/2026 3:43 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 4:10 PM | Dolby Laboratories (1308547) Issuer Pendleton Todd (1746636) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 3:18 PM | Dolby Laboratories (1308547) Subject Pendleton Todd (1746636) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/19/2026 4:31 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:26 PM | Dolby Laboratories (1308547) Issuer Park Robert J (1887569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 2:37 PM | Dolby Laboratories (1308547) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 05/06/2026 4:05 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:16 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/04/2026 3:19 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/30/2026 3:45 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/29/2026 5:24 PM | Dolby Laboratories (1308547) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 11:46 AM | Dolby Laboratories (1308547) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 1:02 PM | Bank of New York Mellon Corp (1390777) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13G/A | |
| 04/03/2026 4:11 PM | Dolby Laboratories (1308547) Issuer Rollins Emily (1847014) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Early bird access on this Black Friday deal (Ad) Markham Trading's Alpha Oracle Signal system is just $7 for Black Friday. Others paid nearly $2,000 for access.
The signal targets a double-digit gain in 5 days. Past results include a $4,120 (36%) Caterpillar winner in 2 days, a $2,740 (30%) Fedex gain in 4 days, and $5,082 (41%) on RTX in 5 days.
Past results are not necessarily indicative of future results. Get Alpha Oracle Signal for $7 before the Black Friday deal expires |
| 04/01/2026 3:06 PM | Dolby Laboratories (1308547) Subject Rollins Emily (1847014) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:03 PM | Dolby Laboratories (1308547) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 4:57 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:00 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:33 PM | Dolby Dagmar (1537372) Filed by Dolby Laboratories (1308547) Subject | Form SCHEDULE 13D/A | |
| 02/11/2026 10:42 AM | Dolby Laboratories (1308547) Subject MORGAN STANLEY (895421) Filed by | Form SCHEDULE 13G/A | |
| 02/09/2026 3:19 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 6:44 PM | Dolby Laboratories (1308547) Issuer Sud Anjali (1775509) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:46 PM | Dolby Laboratories (1308547) Issuer GOTCHER PETER C (935901) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:47 PM | Dolby Laboratories (1308547) Issuer Rollins Emily (1847014) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:50 PM | Dolby David (1511370) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:52 PM | Dolby Laboratories (1308547) Issuer Segars Simon (1632353) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:40 PM | Dolby Laboratories (1308547) Issuer TEVANIAN AVADIS (1214091) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:42 PM | Dolby Laboratories (1308547) Issuer Prophet Tony A (1588813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 3:10 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 4:55 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/29/2026 3:57 PM | Dolby Laboratories (1308547) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 01/29/2026 3:15 PM | Dolby Laboratories (1308547) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 8:44 PM | Dolby Laboratories (1308547) Issuer Pendleton Todd (1746636) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:46 PM | Dolby Laboratories (1308547) Issuer Nicholson Ryan (1767009) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:48 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:38 PM | Dolby Laboratories (1308547) Issuer Park Robert J (1887569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:39 PM | Dolby Laboratories (1308547) Issuer SHERMAN MARK ANDREW (1256708) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:41 PM | Dolby Laboratories (1308547) Issuer Revankar Shriram (1928994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:43 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 3:10 PM | Dolby Laboratories (1308547) Subject SHERMAN MARK ANDREW (1256708) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/17/2025 3:07 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:38 PM | Dolby Laboratories (1308547) Subject SHERMAN MARK ANDREW (1256708) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:47 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 7:44 AM | Dolby Laboratories (1308547) Filer | Form ARS | |
| 12/16/2025 7:30 AM | Dolby Laboratories (1308547) Filer | Form DEF 14A | |
| 12/16/2025 7:32 AM | Dolby Laboratories (1308547) Filer | Form DEFA14A | |
| 12/15/2025 4:03 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 4:04 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/09/2025 3:04 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/03/2025 5:55 PM | Dolby Laboratories (1308547) Issuer SHERMAN MARK ANDREW (1256708) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 7:37 PM | Dolby Laboratories (1308547) Issuer YEAMAN KEVIN J (1200469) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:27 PM | Dolby Laboratories (1308547) Issuer Prophet Tony A (1588813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:32 PM | Dolby Laboratories (1308547) Subject YEAMAN KEVIN J (1200469) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/24/2025 3:44 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 3:07 PM | Dolby Laboratories (1308547) Subject Revankar Shriram (1928994) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/20/2025 3:09 PM | Couling John D (1894052) Reporting Dolby Laboratories (1308547) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 4:01 PM | Dolby Laboratories (1308547) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |